The preparation and pharmacological selection of a new anti-inflammatory agent, thiazolinobutazone.
D000818:Animals; D002351:Carrageenan; D002415:Cats; D004353:Drug Evaluation, Preclinical; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D005260:Female; D006973:Hypertension / Q000139:chemically induced; D008297:Male; D051379:Mice; D010437:Peptic Ulcer / Q000139:chemically induced; D010653:Phenylbutazone / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000627:therapeutic use / Q000633:toxicity; D051381:Rats; D013844:Thiazoles / Q000138:chemical synthesis / Q000627:therapeutic use* / Q000633:toxicity
D013844:Thiazoles; D002351:Carrageenan; D010653:Phenylbutazone